These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24752055)

  • 1. Tumor regression grading in rectal cancer: is it time to move forward?
    Valentini V; Minsky BD
    J Clin Oncol; 2014 May; 32(15):1534-6. PubMed ID: 24752055
    [No Abstract]   [Full Text] [Related]  

  • 2. Practice parameters for the management of rectal cancer (revised).
    Monson JR; Weiser MR; Buie WD; Chang GJ; Rafferty JF; Buie WD; Rafferty J;
    Dis Colon Rectum; 2013 May; 56(5):535-50. PubMed ID: 23575392
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.
    Fokas E; Liersch T; Fietkau R; Hohenberger W; Beissbarth T; Hess C; Becker H; Ghadimi M; Mrak K; Merkel S; Raab HR; Sauer R; Wittekind C; Rödel C
    J Clin Oncol; 2014 May; 32(15):1554-62. PubMed ID: 24752056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of rectal carcinoma after multimodal treatment: ypTNM classification and tumor regression grading are essential.
    Hermanek P; Merkel S; Hohenberger W
    Anticancer Res; 2013 Feb; 33(2):559-66. PubMed ID: 23393349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
    Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extramural depth of rectal cancer tumor invasion at thin-section MRI: predicting treatment response to neoadjuvant chemoradiation.
    Tong T; Sun Y; Cai S; Zhang Z; Gu Y
    Oncotarget; 2015 Oct; 6(30):30277-86. PubMed ID: 26309163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we consider adjuvant therapy for rectal cancer after neoadjuvant chemoradiotherapy?
    Benson AB
    Clin Adv Hematol Oncol; 2016 Oct; 14(10):778-781. PubMed ID: 27930628
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological regression grading matches excellently with local and regional spread after neoadjuvant therapy of rectal cancer.
    Elezkurtaj S; Moser L; Budczies J; Müller AJ; Bläker H; Buhr HJ; Dietel M; Kruschewski M
    Pathol Res Pract; 2013 Jul; 209(7):424-8. PubMed ID: 23706942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAGNETIC RESONANCE IMAGING TO EVALUATE NEOADJUVANT THERAPY EFFECTS ON RECTAL CARCINOMA.
    Sofić A; Vukobrat-Bijedić Z; Husić-Selimović A; Šehović N; Buija D; Eminagić D; Banjin M; Đuran A
    Acta Clin Croat; 2015 Sep; 54(3):303-8. PubMed ID: 26666099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Das P; Eng C; Kopetz S; Wolff RA; Crane CH; Krishnan S; Minsky B; Hu CY; Nguyen S; Chang GJ
    Am J Clin Oncol; 2017 Jun; 40(3):277-282. PubMed ID: 27028350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending neoadjuvant chemotherapy in rectal cancer.
    Roselló S; Cervantes A
    Lancet Oncol; 2015 Aug; 16(8):880-1. PubMed ID: 26187752
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with different results.
    Merkel S; Weber K; Göhl J; Agaimy A; Fietkau R; Hohenberger W; Grützmann R; Hermanek P
    Int J Colorectal Dis; 2017 Sep; 32(9):1295-1301. PubMed ID: 28730369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing pathological complete response rate using oral capecitabine versus infusional 5-fluorouracil with preoperative radiotherapy in rectal cancer treatment.
    Jootun N; Evans T; Mak J; Makin G; Platell C
    ANZ J Surg; 2018 Jan; 88(1-2):62-65. PubMed ID: 28982208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for rectal cancer.
    Bujko K; Glimelius B
    Lancet Oncol; 2014 May; 15(6):e194-5. PubMed ID: 24807860
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant chemotherapy for rectal cancer.
    You K; Huang R; Gao Y
    Lancet Oncol; 2014 May; 15(6):e194. PubMed ID: 24807861
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant chemotherapy for rectal cancer.
    Atkins CD
    Lancet Oncol; 2014 May; 15(6):e195-6. PubMed ID: 24807862
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemotherapy for rectal cancer.
    Valsecchi ME
    Lancet Oncol; 2014 May; 15(6):e195. PubMed ID: 24807863
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant chemotherapy for rectal cancer.
    Thornton M; Rooney PS
    Lancet Oncol; 2014 May; 15(6):e196. PubMed ID: 24807864
    [No Abstract]   [Full Text] [Related]  

  • 20. Diversion with neoadjuvant vs surgery with adjuvant treatment for obstructing rectal cancer?
    Kaiser AM
    Dis Colon Rectum; 2012 Oct; 55(10):e346. PubMed ID: 22965410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.